益丰药房2月25日获融资买入760.34万元，融资余额8259.75万元

Core Viewpoint - Yifeng Pharmacy's stock experienced a slight decline of 0.37% on February 25, with a trading volume of 214 million yuan, indicating a low financing balance and a decrease in shareholder numbers [1][2]. Financing Summary - On February 25, Yifeng Pharmacy had a financing buy amount of 7.60 million yuan and a financing repayment of 7.17 million yuan, resulting in a net financing buy of 436,700 yuan [1]. - The total financing and margin trading balance as of February 25 was 83.66 million yuan, with the financing balance at 82.60 million yuan, accounting for 0.28% of the circulating market value, which is below the 30th percentile level over the past year [1]. - The margin trading aspect showed no shares were repaid, with 6,300 shares sold short, amounting to 152,500 yuan at the closing price, and a margin balance of 1.06 million yuan, also below the 10th percentile level over the past year [1]. Business Performance Summary - As of September 30, Yifeng Pharmacy had 20,200 shareholders, a decrease of 6.41%, while the average circulating shares per person increased by 6.85% to 59,920 shares [2]. - For the period from January to September 2025, Yifeng Pharmacy reported a revenue of 17.29 billion yuan, a year-on-year increase of 0.39%, and a net profit attributable to shareholders of 1.23 billion yuan, reflecting a growth of 10.27% [2]. - The company has distributed a total of 2.85 billion yuan in dividends since its A-share listing, with 1.95 billion yuan distributed over the past three years [2]. Shareholder Structure Summary - As of September 30, 2025, Hong Kong Central Clearing Limited was the second-largest circulating shareholder with 199 million shares, a decrease of 38.19 million shares from the previous period [2]. - Southern CSI 500 ETF ranked as the seventh-largest circulating shareholder with 8.81 million shares, down by 173,100 shares, while交银新成长混合 (Jiaoyin New Growth Mixed) entered the list as the eighth-largest shareholder with 8.45 million shares [2]. - 中欧医疗健康混合A (Zhongou Medical Health Mixed A) has exited the top ten circulating shareholders list [2].